Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.11% is 38% below its 5-year average of 0.17%, near the low end of its 5-year range (0.00%–18.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 52.09% below its 12-month average of 0.22%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.11%.
DEBT TO ASSETS RATIO
0.11%
DEBT TO ASSETS RATIO AVG TTM
0.22%
DEBT TO ASSETS RATIO AVG 3Y
0.22%
DEBT TO ASSETS RATIO AVG 5Y
0.17%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-52.09%
CURRENT VS 3Y AVG
-52.58%
CURRENT VS 5Y AVG
-37.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+17.86%
vs the sector median at left
Dianthus Therapeutics, Inc.
Market Cap
$4.71B
Debt to Assets Ratio
0.11%
TTM Avg
0.22%
3Y Avg
0.22%
5Y Avg
0.17%
Market Cap
$4.69B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.80B
Debt to Assets Ratio
0.73%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.82B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.47B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.43B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.71B | 0.11% | 0.22% | 0.22% | 0.17% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | 0.03% | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.69B | 0.20% | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 0.09% | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 0.38% | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.80B | 0.73% | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.82B | 0.00% | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.47B | 0.08% | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | 0.41% | N/A | N/A | N/A |
| Erasca, Inc. (ERAS)vs › | $5.00B | 0.10% | N/A | N/A | N/A |
Debt/Assets
0.1%
Debt/Equity
0.00
Current Ratio
26.10
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.11% |
| 2026-03-31 | 0.11% |
| 2025-12-31 | 0.26% |
| 2025-09-30 | 0.22% |
| 2025-06-30 | 0.41% |
| 2025-03-31 | 0.40% |
| 2024-12-31 | 0.40% |
| 2024-09-30 | 0.09% |
| 2024-06-30 | 0.11% |
| 2024-03-31 | 0.13% |
| 2023-12-31 | 0.33% |
| 2023-09-30 | 0.35% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.95% |
| 2022-09-30 | 18.77% |
| 2022-06-30 | 18.05% |
| 2022-03-31 | 16.64% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
